MAGEA3 and cancer: In a different study, the Silica Immunoinformatics approach was used to construct a multifunctional vaccine for NSCC cancer that included MHC I, MHC II, CTL, and B-cell epitopes obtained from MAGE-A3 cells, EGF, and MUC-1.